pilsicainide has been researched along with Tachycardia, Paroxysmal in 4 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Tachycardia, Paroxysmal: Abnormally rapid heartbeats with sudden onset and cessation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased dispersion of signal-averaged P wave duration would play an important role in generating paroxysmal atrial fibrillation and would be useful in the prediction of drug efficacy to evaluate the change in dispersion by a single administration of pilsicainide." | 3.70 | Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. ( Asano, Y; Fukunami, M; Hoki, N; Hori, M; Kumagai, K; Ogita, H; Sanada, S; Shimonagata, T; Yamada, T, 1999) |
| "Patient 1 had frequent episodes of paroxysmal atrial fibrillation resistant to Class IA drugs." | 1.30 | ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. ( Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etoh, R | 1 |
| Ishimatsu, T | 1 |
| Kawano, H | 1 |
| Tomichi, Y | 1 |
| Arakawa, S | 1 |
| Doi, Y | 1 |
| Fukae, S | 1 |
| Maemura, K | 1 |
| Yamada, T | 1 |
| Fukunami, M | 1 |
| Shimonagata, T | 1 |
| Kumagai, K | 1 |
| Sanada, S | 1 |
| Ogita, H | 1 |
| Asano, Y | 1 |
| Hori, M | 1 |
| Hoki, N | 1 |
| Fujiki, A | 1 |
| Usui, M | 1 |
| Nagasawa, H | 1 |
| Mizumaki, K | 1 |
| Hayashi, H | 1 |
| Inoue, H | 1 |
| Tükek, T | 1 |
| Akkaya, V | 1 |
| Demirel, S | 1 |
| Sözen, AB | 1 |
| Kudat, H | 1 |
| Atilgan, D | 1 |
| Ozcan, M | 1 |
| Güven, O | 1 |
| Korkut, F | 1 |
4 other studies available for pilsicainide and Tachycardia, Paroxysmal
| Article | Year |
|---|---|
Successful treatment for various arrhythmias in an older patient treated with pilsicainide for paroxysmal supraventricular tachycardia.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Lidocaine; Tachycard | 2018 |
Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; B | 1999 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Hea | 1999 |
Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Heart Rate; Humans; Lidoca | 2000 |